Variable | Training set(n = 214) | Validation set(n = 72) | p |
---|---|---|---|
Pulmonary fungal infection [n(%)] | |||
Yes | 102 (47.7) | 41 (56.9) | 0.173 |
No | 112 (52.3) | 31 (43.1) | Â |
Age [n(%)] | |||
 > 65 years old | 54 (25.2) | 16 (22.2) | 0.607 |
 ≤ 65 years old | 160 (74.8) | 56 (77.8) |  |
Gender [n(%)] | |||
Male | 164 (76.6) | 48 (66.7) | 0.095 |
Female | 50 (23.4) | 24 (33.3) | Â |
Address [n(%)] | |||
North | 206 (96.3) | 71 (98.6) | 0.458 |
South | 8 (3.7) | 1 (1.4) | Â |
Smoke [n(%)] | |||
Yes | 89 (41.6) | 29 (40.3) | 0.845 |
No | 125 (58.4) | 43 (59.7) | Â |
Drink [n(%)] | |||
Yes | 67 (31.3) | 22 (30.6) | Â |
No | 147 (68.7) | 50 (69.4) | 0.905 |
Category [n(%)] | |||
Initial | 155 (72.4) | 16 (22.2) | 0.372 |
Recurrent | 59 (27.6) | 56 (77.8) | Â |
Drug resistance [n(%)] | |||
No drug resistance | 178 (83.2) | 59 (81.9) | 0.563 |
Single drug resistance | 17 (7.9) | 4 (5.6) | Â |
Other drug resistance | 19 (8.9) | 9 (12.5) | Â |
Illness course [n(%)] | |||
 ≤ 1 year | 104 (48.6) | 33 (45.8) | 0.062 |
 > 1 year, ≤ 5 years | 59 (27.6) | 13 (18.1) |  |
 > 5 years, ≤ 10 years | 19 (8.9) | 14 (19.4) |  |
 > 10 years | 32 (15.0) | 12 (16.7) |  |
Pulmonary cavitation [n(%)] | |||
Yes | 126 (58.9) | 34 (7.2) | 0.085 |
No | 88 (41.1) | 38 (52.8) | Â |
Pleural effusion [n(%)] | |||
Yes | 82 (38.3) | 25 (34.7) | 0.585 |
No | 132 (61.7) | 47 (65.3) | Â |
Regular anti-tuberculosis [n(%)] | |||
Yes | 121 (56.5) | 42 (58.3) | 0.791 |
No | 93 (43.5) | 30 (41.7) | Â |
Broad-spectrum antibiotics were used for at least 1Â week [n(%)] | |||
Yes | 89 (41.6) | 35 (48.6) | 0.298 |
No | 125 (58.4) | 37 (51.4) | Â |
Glucocorticoid were used for at least 2Â weeks [n(%)] | |||
Yes | 31 (14.5) | 8 (11.1) | 0.470 |
No | 183 (85.5) | 64 (88.9) | Â |
Chemotherapy or immunosuppressants [n(%)] | |||
Yes | 10 (4.7) | 1 (1.4) | 0.210 |
No | 204(95.3) | 71(98.6) | Â |
Invasive operation [n(%)] | |||
Yes | 150 (70.1) | 48 (66.7) | 0.586 |
No | 64 (29.9) | 24 (33.3) | Â |
Surgery [n(%)] | |||
Yes | 81 (37.9) | 27 (37.5) | Â |
No | 133 (62.1) | 45 (62.5) | 0.958 |
Bacterial pneumonia [n(%)] | |||
Yes | 27 (12.6) | 12 (16.7) | 0.386 |
No | 187 (87.4) | 60 (83.3) | Â |
Chronic bronchitis/ COPD/Bronchiectasis/Asthma [n(%)] | |||
Yes | 28 (13.1) | 8 (11.1) | 0.662 |
No | 186 (86.9) | 64 (88.9) | Â |
Silicosis [n(%)] | |||
Yes | 3 (1.4) | 4 (5.6) | 0.070 |
No | 211 (98.6) | 68 (94.4) | Â |
Interstitial lung disease [n(%)] | |||
Yes | 7 (3.3) | 2 (2.8) | 1.000 |
No | 207 (96.7) | 70 (97.2) | Â |
Hepatic injury [n(%)] | |||
Yes | 68 (31.8) | 18 (25.0) | Â |
No | 146 (68.2) | 54 (75.0) | 0.278 |
Renal inadequacy [n(%)] | |||
Yes | 15 (7.0) | 1 (1.4) | 0.081 |
No | 199 (93.0) | 71 (98.6) | Â |
Tumor / Hematological disease [n(%)] | |||
Yes | 12 (5.6) | 5 (6.9) | 0.773 |
No | 202 (94.4) | 67 (93.1) | Â |
Hypoproteinemia [n(%)] | |||
Yes | 77 (36.0) | 28 (38.9) | 0.658 |
No | 137 (64.0) | 44 (61.1) | Â |
Anemia [n(%)] | |||
Yes | 62 (29.0) | 21 (29.2) | 0.975 |
No | 152 (71.0) | 51 (70.8) | Â |
Diabetes [n(%)] | |||
Yes | 49 (22.9) | 19 (26.4) | 0.547 |
No | 165 (77.1) | 53 (73.6) | Â |